"Neoplasm Grading" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Methods which attempt to express in replicable terms the level of CELL DIFFERENTIATION in neoplasms as increasing ANAPLASIA correlates with the aggressiveness of the neoplasm.
| Descriptor ID |
D060787
|
| MeSH Number(s) |
E01.789.612
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Neoplasm Grading".
Below are MeSH descriptors whose meaning is more specific than "Neoplasm Grading".
This graph shows the total number of publications written about "Neoplasm Grading" by people in this website by year, and whether "Neoplasm Grading" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 7 | 7 |
| 2012 | 0 | 22 | 22 |
| 2013 | 1 | 20 | 21 |
| 2014 | 0 | 19 | 19 |
| 2015 | 1 | 25 | 26 |
| 2016 | 1 | 24 | 25 |
| 2017 | 2 | 24 | 26 |
| 2018 | 1 | 27 | 28 |
| 2019 | 4 | 20 | 24 |
| 2020 | 2 | 15 | 17 |
| 2021 | 0 | 10 | 10 |
| 2022 | 0 | 6 | 6 |
| 2023 | 0 | 10 | 10 |
| 2024 | 2 | 14 | 16 |
| 2025 | 1 | 10 | 11 |
| 2026 | 1 | 7 | 8 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplasm Grading" by people in Profiles.
-
Prostate Cancer Mortality After Relabeling Low-Grade Prostate Cancer as Precancerous. JAMA Oncol. 2026 07 01; 12(7):767-771.
-
Water Vapor Therapy for the Management of Prostate Cancer: The VAPOR 2 Study Initial Results of Ablative Efficacy and Toxicity. J Urol. 2026 Oct; 216(4):527-539.
-
Updates and controversies in contemporary grading of clear cell renal cell carcinoma and papillary renal cell carcinoma. Histopathology. 2026 Oct; 89(4):574-589.
-
Long-Term Analysis of NRG Oncology RTOG 0539: A Phase II Trial of Observation for Low-Risk Meningioma and Radiotherapy for Intermediate- and High-Risk Meningioma. J Clin Oncol. 2026 Aug 10; 44(23):2169-2175.
-
Columnar Cell Subtype of Papillary Thyroid Carcinoma Is Characterized By A High Frequency of High-Grade Tumors That Exhibit Aggressive Clinicopathologic Features and Poor Outcomes: A Multicenter Study of 71 Cases. Am J Surg Pathol. 2026 Aug 01; 50(8):865-871.
-
The Ki-67 proliferation index and recurrence risk of intracranial meningioma: a multicenter, retrospective cohort study of 5,050 patients. Acta Neurochir (Wien). 2026 04 06; 168(1).
-
Automated Cluster-based Quantitative Analysis of Ultrafast DCE MRI for Differential Breast DCIS Grading. Radiol Imaging Cancer. 2026 Mar; 8(2):e250432.
-
The Genitourinary Pathology Society and International Society of Urological Pathology Joint Expert Consultation Recommendations on intraductal carcinoma of the prostate. Histopathology. 2026 Jan; 88(1):8-23.
-
Twelve-Month Results From the CISTO Study Comparing Radical Cystectomy Versus Bladder-Sparing Therapy for Recurrent High-Grade Non-Muscle-Invasive Bladder Cancer. J Clin Oncol. 2026 02; 44(4):274-285.
-
Real-World Single-Center Experience with Neoadjuvant Gemcitabine, Cisplatin, and Durvalumab in Borderline Resectable Cholangiocarcinoma. Ann Surg Oncol. 2025 Oct; 32(10):7228-7239.